Cite
MLA Citation
Leisha Emens et al.. “317 A phase 1/1b study of SBT6050, a HER2-directed monoclonal antibody conjugated to a toll-like receptor 8 agonist, in subjects with advanced HER2-expressing solid tumors.” Journal for immunotherapy of cancer, vol. 8, n.d., p. A343. http://access.bl.uk/ark:/81055/vdc_100144721172.0x000004